Table 2.
Gender | Diseases | Trends (1) | Trends (2) | AAPC (95% CI, %) | ||
---|---|---|---|---|---|---|
Year-range | APC (95% CI, %) | Year-range | APC (95% CI, %) | |||
Male | Malignant Tumor | 2000–2007 | 4.5 (2.5–6.6)* | 2007–2017 | − 1.1 (− 2.2–0.1) | 1.0 (0.2–1.8)* |
Cerebrovascular Disease | 2000–2017 | 1.4 (0.7–2.2)* | – | – | 1.4 (0.7–2.2)* | |
Heart Trouble | 2000–2005 | 0.1 (− 5.3–5.8) | 2005–2017 | 5.0 (3.5–6.6)* | 3.9 (2.9–4.9)* | |
Respiratory Disease | 2000–2017 | − 3.3 (− 4.5– − 2.2)* | – | – | − 3.3 (− 4.5– − 2.2)* | |
Trauma and Toxicosis | 2000–2017 | − 0.6 (− 1.6–0.4) | – | – | − 0.6 (− 1.6–0.4) | |
Female | Malignant Tumor | 2000–2017 | 1.0 (− 0.1–2.0) | – | – | 1.0 (− 0.1–2.0) |
Cerebrovascular Disease | 2000–2003 | 10.7 (0.9–21.4)* | 2003–2017 | 1.2 (0.3–2.1)* | 2.8 (1.2–4.5)* | |
Heart Trouble | 2000–2005 | 0.7 (− 4.4–6.1) | 2005–2017 | 5.1 (3.7–6.6)* | 4.1 (3.2–5.0)* | |
Respiratory Disease | 2000–2017 | − 4.0 (− 5.3– − 2.8)* | – | – | − 4.0 (− 5.3– − 2.8)* | |
Trauma and Toxicosis | 2000–2003 | − 13.7 (− 22.9– − 3.4)* | 2003–2017 | 0.1 (− 1.0–1.1) | − 2.5 (− 4.4– − 0.6)* | |
All | Malignant Tumor | 2000–2003 | 11.4 (1.8–21.9)* | 2003–2017 | − 0.3 (− 1.1–0.6) | 1.7 (0.1–3.3)* |
Cerebrovascular Disease | 2000–2017 | 1.5 (0.6–2.5)* | – | – | 1.5 (0.6–2.5)* | |
Heart Trouble | 2000–2005 | 0.1 (− 4.3–4.7) | 2005–2017 | 5.5 (4.3–6.8)* | 4.3 (3.4–5.2)* | |
Respiratory Disease | 2000–2017 | − 3.6 (− 4.8– − 2.3)* | – | – | − 3.6 (− 4.8– − 2.3)* | |
Trauma and Toxicosis | 2000–2003 | − 13.2 (− 23.1– − 2.1)* | 2003–2017 | 0.8 (− 0.3–1.9) | − 0.7 (− 2.1–0.8) |
APC Annual Percent Change; AAPC Average Annual Percent Change; CI confidence interval.
Significant values are in bold.
*Indicates that AAPC or APC is significantly different from zero at the alpha = 0.05 level.